Thyroid Lymphoma

Common Name(s)

Thyroid Lymphoma

Thyroid lymphoma is a cancer of the lymphatic system that arises from the thyroid gland. The lymphatic system is part of the body's immune system that helps fight infection. It is made up of organs such as the bone marrow, thymus, spleen, and lymph nodes. Primary thyroid lymphomas are usually always non-Hodgkin lymphomas (NHLs) and can be divided into aggressive and slowly developing cell types. The most common symptoms of thyroid lymphoma is a lump in the front of the neck. Once diagnosed, thyroid NHL is highly curable without the need for surgery. Treatment may include radiotherapy, chemotherapy, or steroids. It usually occurs in people over the age of 60 and is more common in women than in men.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thyroid Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thyroid Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Thyroid Lymphoma" returned 80 free, full-text research articles on human participants. First 3 results:

An Unwonted Clinicopathological Subtype of Thyroid Primary Lymphoma.
 

Author(s): Mihai Radu Diaconescu, Ioan Costea, Mihai Glod, Smaranda Diaconescu,

Journal: Chirurgia (Bucur). ;111(5):428-431.

 

Primary thyroid lymphomas account for less than 5% of all thyroid malignancies and the majority of cases concern non- Hodgkin's lymphoma of B and T-cell origin as well as Hodgkin's lymphoma. Mucosa-associated lymphoid tissue (MALT) lymphoma are a relatively recently described subset ...

Last Updated: 7 Nov 2016

Go To URL
Development of Primary Thyroid Lymphoma during an Ultrasonographic Follow-up of Hashimoto's Thyroiditis: A Report of 9 Cases.
 

Author(s): Tetsuya Mizokami, Katsuhiko Hamada, Tetsushi Maruta, Kiichiro Higashi, Hiroto Yamashita, Yasushi Noguchi, Hitoshi Noguchi, Junichi Tajiri

Journal: Intern. Med.. 2016 ;55(8):943-8.

 

We herein experienced 9 patients with primary thyroid lymphoma that developed during 3-18 years of ultrasonographic follow-up of Hashimoto's thyroiditis. All nine patients had localized mucosa-associated lymphoid tissue (MALT) lymphoma. Two patients had diffuse type, one had mixed ...

Last Updated: 18 Apr 2016

Go To URL
Evaluation of primary thyroid lymphoma by ultrasonography combined with contrast-enhanced ultrasonography: A pilot study.
 

Author(s): X Wei, Y Li, S Zhang, X Li, M Gao

Journal: Indian J Cancer. ;52(4):546-50.

 

To evaluate the features of primary thyroid lymphoma (PTL) by ultrasonography (US) combined with contrast-enhanced ultrasonography (CEUS).

Last Updated: 10 Mar 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Thyroid Lymphoma" returned 12 free, full-text review articles on human participants. First 3 results:

Primary Thyroid Extranasal NK/T-Cell Lymphoma Associated With Good Outcome: A Case Report and Literature Review: A Care-Compliant Article.
 

Author(s): Jun-He Li, Hong-Hong He, Yuan Cheng, Wen-Jing He

Journal: Medicine (Baltimore). 2016 May;95(20):e3460.

 

Most thyroid lymphomas are B-lineage, and T-cell lymphomas are rare. None of primary thyroid extranasal NK/T-cell lymphoma (NKTCL) has been reported in the literature. Here, we report a case of extranasal NKTCL exclusively arising in the thyroid in an 18-year-old Chinese.The patient ...

Last Updated: 20 May 2016

Go To URL
Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.
 

Author(s): Chengze Chen, Yinlong Yang, Langping Jin, Lei Dong, Xiaohua Zhang, Youqun Xiang

Journal:

 

Most thyroid lymphomas are B-lineage, and T-cell lymphomas are rare. Here, we report a case of primary T-cell lymphoblastic lymphoma (T-LBL) of the thyroid gland. A 15-year-old boy presented with a painless thyroid mass. Ultrasonographic examination revealed a hypoechoic thyroid nodule ...

Last Updated: 15 Jan 2014

Go To URL
Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.
 

Author(s): Elena Vigliar, Alessia Caleo, Mario Vitale, Vincenzo Di Crescenzo, Alfredo Garzi, Pio Zeppa

Journal: BMC Surg. 2013 ;13 Suppl 2():S49.

 

Primary thyroid lymphomas (PTLs) account for 5% of thyroid malignant tumors and often develop in patients with Hashimoto Thyroiditis (HT). Fine-needle cytology (FNC) is widely used in the diagnosis of thyroid nodules, including those arising in HT. Two PTL cases in HT elderly patients ...

Last Updated: 25 Nov 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
 

Status: Recruiting

Condition Summary: Glioma; Lymphoma; Metastatic Solid Neoplasm; Neuroendocrine Neoplasm; Recurrent Adult Soft Tissue Sarcoma; Recurrent Bladder Carcinoma; Recurrent Breast Carcinoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Colorectal Carcinoma; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Head and Neck Carcinoma; Recurrent Lung Carcinoma; Recurrent Melanoma; Recurrent Pancreatic Carcinoma; Recurrent Prostate Carcinoma; Recurrent Renal Cell Carcinoma; Recurrent Solid Neoplasm; Recurrent Thyroid Gland Carcinoma; Refractory Chronic Lymphocytic Leukemia; Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Stage III Lung Cancer; Stage III Pancreatic Cancer; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Soft Tissue Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Colorectal Cancer; Stage IIIA Skin Melanoma; Stage IIIB Breast Cancer; Stage IIIB Colorectal Cancer; Stage IIIB Skin Melanoma; Stage IIIC Breast Cancer; Stage IIIC Colorectal Cancer; Stage IIIC Skin Melanoma; Stage IV Breast Cancer; Stage IV Lung Cancer; Stage IV Pancreatic Cancer; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Skin Melanoma; Stage IV Soft Tissue Sarcoma; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer; Unresectable Solid Neoplasm

 

Last Updated: 1 Feb 2017

Go to URL
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
 

Status: Recruiting

Condition Summary: Hematological Neoplasms; Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Lymphoma; Multiple Myeloma; Acute Myeloid Leukemia; Leukemia; Myelodysplastic Syndromes; Neoplasms; Melanoma; Breast Cancer; Metastatic Breast Cancer; Non-Small Cell Lung Cancer; Small Cell Lung Cancer; Renal Cell Carcinoma; Glioblastoma Multiforme; Osteosarcoma; Sarcoma; Thyroid Cancer; Genitourinary

 

Last Updated: 24 Oct 2016

Go to URL
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
 

Status: Recruiting

Condition Summary: Breast Cancer; Cholangiocarcinoma; Colorectal Cancer; Head and Neck Neoplasms; Lymphoma, Large-Cell, Anaplastic; Melanoma; Neuroendocrine Tumors; Non-Small Cell Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Primary Brain Tumors; Renal Cell Carcinoma; Sarcomas; Salivary Gland Cancers; Adult Solid Tumor

 

Last Updated: 24 Feb 2017

Go to URL